{
    "Trade/Device Name(s)": [
        "ISE Electrodes"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K230890",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052914",
        "K131554"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEM",
        "CGZ",
        "JGS"
    ],
    "Summary Letter Date": "August 11, 2023",
    "Summary Letter Received Date": "August 11, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1600",
        "21 CFR 862.1170",
        "21 CFR 862.1665"
    ],
    "Regulation Name(s)": [
        "Potassium Test System",
        "Chloride Test System",
        "Sodium Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX imola"
    ],
    "Method(s)/Technology(ies)": [
        "Ion Selective Electrode (ISE)",
        "Direct measurement"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Electrochemical analysis"
    ],
    "Submission Type(s)": [
        "Electrode",
        "Analyzer",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for ISE Electrodes on RX imola for quantitative measurement of sodium, potassium, and chloride in serum and urine to aid diagnosis and treatment of electrolyte imbalance",
    "Indications for Use Summary": "Measurement of sodium, potassium, and chloride in serum and urine to aid in diagnosis and treatment of electrolyte imbalance; for in vitro diagnostic use only",
    "fda_folder": "Clinical Chemistry"
}